Diabetes
Every diagnostic system has to be tested for potential interfering factors during development. For this essential step in assay validation, we have put together ideally composed collections of human biospecimens. The interfering factors of an in vitro diagnostic test (IVD) can be analysed with the panel of interfering substances, which is available here. Besides an interference panel, biospecimen collections of patients with rheumatoid arthritis, diabetes (type I and II) and obesity are available. Panels of pregnant women and elderly people cover other potentially interfering factors during assay development. If you do not find the panel you are looking for, please contact our Central BioHub team.
1 Product
Human Diabetes Panel (20 serum samples: 1 mL each) - Diabetes Typ I, Diabetes Typ II
- Donor:
- Gender: Not specified
- Parameter:
- Diabetes Typ I Diabetes Typ II
Donor:
- Gender:
- Not specified
- Age:
- Years
Sample:
- Matrix:
- Diabetes Panel (20 serum samples: 1 mL each)
- Stored at:
- < -18 °C
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Diabetes Typ I |
Qual: positive
Quant:
Source:
Remarks: 10 samples (IAA values will be provided if available) |
|
|
| Diabetes Typ II |
Qual: positive
Quant:
Source:
Remarks: 10 samples (HbA1c values and/or blood glucose levels will be provided) |
|
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH299334
20 mL (€750.00)
- <
- 1
- >
